(FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | (Q1)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 4.49%-3.05M | -1,132.69%-659.65K | -21.05%-1.23M | 83.61%-139K | 19.99%-1.02M | -18.83%-3.19M | 95.64%-53.51K | -169.76%-1.02M | -0.20%-848.26K | -437.71%-1.27M |
Net income from continuing operations | -613.95%-47.37M | -32.65%-1.59M | 51.18%-2.1M | -3,757.37%-41.74M | -3,162.08%-1.94M | -70.85%-6.64M | 6.28%-1.2M | -274.04%-4.29M | 30.34%-1.08M | -161.12%-59.59K |
Operating gains losses | 138.70%187.21K | 136.62%179.98K | -1,542.56%-556.53K | 25.54%589.89K | 94.78%-26.13K | -134.02%-483.74K | -129.93%-491.52K | 462.38%38.58K | --469.87K | ---500.67K |
Depreciation and amortization | 148.56%156.13K | -205.24%-21.79K | 93.94%41.99K | 550.61%72.58K | 581.36%63.35K | 49.60%62.81K | 149.04%20.71K | 99.46%21.65K | -2.22%11.16K | -18.50%9.3K |
Asset impairment expenditure | -2.06%919.19K | -111,032.29%-38.86M | -16.61%753.39K | ---- | ---- | --938.49K | --35.03K | --903.46K | ---- | ---- |
Unrealized gains and losses of investment securities | 123.20%1.28M | -21.01%522.1K | -70.58%308.6K | 89.81%-38.86K | 165.19%491.34K | -19.08%574.9K | 5,811.81%660.97K | 41.06%1.05M | -153.66%-381.39K | -2.92%-753.69K |
Remuneration paid in stock | 44.22%2.34M | 111.09%5.34K | -79.68%287.61K | 868.51%1.51M | 436.52%543.69K | 226.54%1.62M | -119.20%-48.13K | 20,115.80%1.42M | -13.19%155.39K | 67.50%101.34K |
Other non cashItems | 5,773.53%39.47M | 5,776.14%39.43M | --3.11K | --18.17K | --18.35K | --671.96K | --670.99K | ---- | ---- | ---- |
Change In working capital | -156.15%-30.47K | -209.91%-327.31K | 116.99%25.9K | 2,165.47%436.37K | -136.40%-165.42K | -64.67%54.27K | 1,427.56%297.8K | -6,630.63%-152.43K | 89.13%-21.13K | -121.46%-69.98K |
-Change in receivables | 78.61%-17.79K | -151.81%-55.97K | 373.39%48.34K | 64.51%-67.35K | 252.54%57.19K | -1,684.77%-83.19K | -5.43%108.04K | 77.96%-17.68K | -157.11%-189.76K | -53.84%16.22K |
-Change in prepaid assets | -960.48%-37.44K | 86.39%-9.57K | -152.18%-21.52K | -152.49%-45.09K | 164.12%38.75K | -126.70%-3.53K | 14.69%-70.26K | -16.83%41.25K | 91.05%85.91K | -6,030.13%-60.43K |
-Change in payables and accrued expense | -82.44%24.76K | -200.67%-261.78K | 99.47%-926 | 563.41%548.82K | -914.19%-261.36K | -2.81%140.99K | 2,201.02%260.02K | -633.81%-175.99K | 149.99%82.73K | -108.89%-25.77K |
Cash from discontinued investing activities | 52.79%-216.81K | -459.28K | ||||||||
Operating cash flow | 10.56%-3.27M | -70.92%-876.46K | -21.05%-1.23M | 83.61%-139K | 19.99%-1.02M | -35.92%-3.65M | 58.19%-512.79K | -169.76%-1.02M | -0.20%-848.26K | -437.71%-1.27M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -5.33%-5.85M | -216.51%-2.78M | 286.63%3.49M | -138.77%-3.77M | -127.49%-2.8M | 27.06%-5.56M | 73.61%-877.76K | -23.92%-1.87M | -56.70%-1.58M | 30.72%-1.23M |
Net PPE purchase and sale | -126.24%-12.24M | -264.56%-2.82M | -58.28%-2.89M | -116.54%-6.08M | ---445.03K | -189.41%-5.41M | 56.25%-773.07K | -3,882.80%-1.83M | ---2.81M | --0 |
Net business purchase and sale | --6.41M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net investment purchase and sale | 84.00%-23.79K | 138.37%40.17K | 46.92%-23.34K | -263.16%-40.61K | --0 | 9.94%-148.65K | -166.71%-104.68K | -75.28%-43.97K | 18.05%24.89K | 79.57%-24.89K |
Net other investing changes | ---- | ---- | ---- | ---- | -95.25%-2.35M | ---- | ---- | ---- | ---- | 24.55%-1.2M |
Cash from discontinued investing activities | 55.44%-795.94K | -1.79M | ||||||||
Investing cash flow | 9.45%-6.65M | -34.17%-3.57M | 286.63%3.49M | -138.77%-3.77M | -127.49%-2.8M | 3.61%-7.34M | 19.92%-2.66M | -23.92%-1.87M | -56.70%-1.58M | 30.72%-1.23M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -24.71%10.47M | 3,798.07%8.4M | 8,247.27%1.27M | -94.57%741.78K | 62.02K | -7.95%13.9M | -97.27%215.42K | -99.79%15.18K | 13.67M | 0 |
Net issuance payments of debt | -432.49%-100.1K | --0 | -6.96%-13.29K | ---34.87K | ---51.94K | ---18.8K | ---6.38K | ---12.42K | --0 | --0 |
Net common stock issuance | -24.09%10.57M | 3,685.98%8.4M | 4,539.13%1.28M | -93.60%875.11K | --15.5K | -11.26%13.92M | -97.82%221.8K | -99.50%27.6K | --13.67M | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | --98.46K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | -100.00%-73.1K | -36.55K | ||||||||
Financing cash flow | -25.04%10.4M | 4,553.76%8.32M | 8,247.27%1.27M | -94.57%741.78K | --62.02K | -8.20%13.87M | -97.73%178.87K | -99.79%15.18K | --13.67M | --0 |
Net cash flow | ||||||||||
Beginning cash position | 20.91%14.68M | -37.69%11.25M | -63.36%7.62M | 11.48%10.78M | 20.91%14.68M | 64.37%12.14M | 103.97%18.05M | 496.91%20.79M | 79.94%9.67M | 64.37%12.14M |
Current changes in cash | -83.32%478.72K | 229.22%3.87M | 222.71%3.53M | -128.17%-3.17M | -49.99%-3.75M | -40.17%2.87M | -189.86%-3M | -153.57%-2.87M | 694.69%11.25M | -24.42%-2.5M |
Effect of exchange rate changes | 202.13%338.37K | 202.22%378.48K | -22.15%99.38K | 104.28%5.22K | -535.14%-144.72K | -663.93%-331.32K | -753.72%-370.27K | --127.65K | ---121.96K | --33.26K |
End cash Position | 5.57%15.5M | 5.57%15.5M | -37.69%11.25M | -63.36%7.62M | 11.48%10.78M | 20.91%14.68M | 20.91%14.68M | 103.97%18.05M | 496.91%20.79M | 79.94%9.67M |
Free cash from | -71.10%-15.5M | -187.34%-3.69M | -44.96%-4.12M | -70.12%-6.22M | -14.96%-1.46M | -98.88%-9.06M | 57.04%-1.29M | -572.21%-2.85M | -331.99%-3.66M | -334.60%-1.27M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data